Cell BiologybioRxivPreprint
Systemic delivery of a CXCR4-CXCL12 signaling inhibitor encapsulated in synthetic protein nanoparticles for glioma immunotherapy
M. S. Alghamri, K. Banerjee, A. A. Mujeeb…·M. G. Castro
This paper develops synthetic protein nanoparticles delivering a CXCR4 inhibitor to treat glioma by enhancing immunotherapy and reducing tumor progression.
DOI 10.1101/2021.08.27.457953